Search Results
Aug 12, 2026, 08:46 ET Borr Drilling Limited - Filing of Interim Financial Report on Form 6-K
2026 /PRNewswire/ -- Borr Drilling Limited (NYSE: BORR) (OSE: BORR) (the "Company") today filed its unaudited interim financial report on Form 6-K for the three and six months ended June 30, 2026 with the U.S. Securities and Exchange Commission ("SEC"). The report is enclosed with this release. The
More news about: Borr Drilling Limited
Aug 12, 2026, 08:35 ET Energy Fuels' Acquisition of Australian Strategic Materials Wins Shareholder Approval
western-produced REE products; and the other factors described under the caption "Risk Factors" in Energy Fuels' most recently filed Annual Report on Form 10-K, which is available for review on EDGAR at
More news about: Energy Fuels Inc.
Aug 12, 2026, 08:34 ET NABJ26 Unveils Signature Events Lineup: A Week of Honors, Wellness, Entertainment and Celebration in Atlanta
15Saturday morning opens with wellness. At 7:30 a.m., attendees will lace up for the NABJ 5K Run/Walk along Atlanta's Westside Beltline. Open to all fitness levels, the 5K brings members, families, friends and supporters together for a morning of fellowship, complete with finisher
More news about: National Association of Black Journalists
Aug 12, 2026, 08:32 ET ChronicCareIQ Appoints Tom Visotsky as Chief Revenue Officer
easier to care for between visits, providers using ChronicCareIQ reduce demands on staff by converting reactive care to proactive prevention, add $13k per doctor per month in new reimbursements and reduce all-cause hospitalizations by 29.4%. Find out how real we are at
More news about: ChronicCareIQ
Aug 12, 2026, 08:28 ET AMN Healthcare Report Projects Persistent Workforce Strain Across Nursing, Allied Health, Physicians and Advanced Practitioners Through 2030
by the forward-looking statements contained in this press release and related white paper are outlined in (i) the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and (ii) its subsequent periodic reports, current reports, and other SEC filings. Be advised that
More news about: AMN Healthcare Services, Inc.
Aug 12, 2026, 08:17 ET Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
render its products obsolete; downturns in domestic and foreign economies; and other risks identified in Volition's most recent Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and other documents filed with the Securities and Exchange Commission.Forward-looking statements are made
More news about: VolitionRx Limited
Aug 12, 2026, 08:06 ET Neuralytix Announces Full Commercial Availability of iD3 System for Intraoperative Nerve Assessment in Spine Surgery
mechanomyography (MMG) technology for objective, real-time intraoperative nerve assessment during spine surgery. The iD3 System is FDA 510(k) cleared (K243636/K260992). For more information, visit
More news about: Neuralytix
Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
obtains approval, it will be successfully distributed and marketed; and other risks and uncertainties described in the Company's annual report on Form 10-K for the year ended December 31, 2025 as filed with the Securities and Exchange Commission on March 12 2026, and in the Company's subsequent filings with
More news about: Acurx Pharmaceuticals, Inc.
Aug 12, 2026, 08:00 ET Netlist Files Patent Infringement Action Against Micron in the U.S. International Trade Commission
expressed in or implied by any forward-looking statements. These and other risks and uncertainties are described in Netlist's Annual Report on Form 10-K for the fiscal year ended December 27, 2025 filed with the SEC on March 19, 2026, and the other filings it makes with the U.S. Securities and Exchange
More news about: Netlist, Inc.
Aug 12, 2026, 08:00 ET Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
available on the SEC's website at www.sec.gov, including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2025, filed with the SEC on December 23, 2025. These forward-looking statements speak only as of the date hereof, and
More news about: Citius Oncology, Inc.
Aug 12, 2026, 08:00 ET Leading Independent Proxy Advisory Firm ISS Recommends LivePerson Stockholders Vote "FOR" Proposed Transaction with SoundHound AI
https://www.sec.gov/Archives/edgar/data/1102993/000121390026076759/ea0297465-01.htm. Further information about the directors and executive officers of LivePerson may be found in its amendment to its Annual Report on Form 10-K for the year ended December 31, 2025 under the headings "Directors, Executive Officers and Corporate Governance," "Executive Compensation," "Security
More news about: LivePerson, Inc.
Aug 12, 2026, 07:30 ET Zoomcar to Announce Q1 FY26-27 Results on August 14, 2026
uncertainties that could cause actual results to differ materially. Key risk factors are detailed in Zoomcar's SEC filings, including its latest Form 10-K and Form 10-Q, available at www.sec.gov. Zoomcar assumes no obligation to update these
More news about: Zoomcar
Aug 12, 2026, 07:15 ET Local Bounti Announces Second Quarter 2026 Financial Results
uncertainties indicated from time to time, including those under "Risk Factors" and "Forward-Looking Statements" in Local Bounti's Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 27, 2026, as supplemented by other reports and documents Local Bounti files from time
More news about: Local Bounti
Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties,
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties,
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties,
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 06:55 ET Trimble Announces Second Quarter 2026 Results and Raises Full Year Guidance
time in reports filed with the U.S. Securities and Exchange Commission, including our quarterly reports on Form 10-Q and our annual report on Form 10-K. Undue reliance should not be placed on any forward-looking statement contained herein. These statements reflect the Company's position as of the date
More news about: Trimble
Aug 12, 2026, 06:45 ET Lazard Reports July 2026 Assets Under Management
include, but are not limited to, those discussed in our Annual Report on Form 10-K under Item 1A "Risk Factors," and also discussed from time to time in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including the following:Adverse general economic conditions
More news about: Lazard
Aug 12, 2026, 06:45 ET BRINKER INTERNATIONAL REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2026 RESULTS AND PROVIDES FISCAL 2027 GUIDANCE
available on Brinker's website under the Financial Information section of the Investor tab.Forward CalendarSEC Form 10-K for the year of fiscal 2026 filing on or before August 24, 2026Earnings release call for the first quarter of fiscal 2027 on
More news about: Brinker International Payroll Company, L.P.
Aug 12, 2026, 06:30 ET Bio-Techne Declares Dividend
relationships.For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:30 ET ITURAN PRESENTS SECOND QUARTER 2026 RESULTS
https://us06web.zoom.us/webinar/register/WN_mE4jXN-IS0ufW5K5ZyeaUgFor those unable to listen to the live call, a replay of the call will be available from the day
More news about: Ituran Location and Control Ltd.
Aug 12, 2026, 06:30 ET Valens Semiconductor Reports Strong Second Quarter 2026 Results and Raises Full-Year Revenue Guidance
the VS6320 chipsets, expanding engagements, and generating new sales opportunities.Introduced a new reference design offering for USB3 and 4K video extension tailored to the needs of our leading ODM customers, driving millions of dollars in bookings.Advanced all four Automotive design-win
More news about: Valens Semiconductor
Aug 12, 2026, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
concerning these risks, uncertainties, and other factors, see the section titled "Risk Factors" in the Company's most recent annual report on Form 10-K as filed with the Securities and Exchange Commission. We undertake and we expressly disclaim any obligation to update or revise any forward-looking statements
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:15 ET Epson Wins Two Awards from Spaces4Learning for its Inkjet Printers for Education
Epson Business Inkjet Color MFPs Recognized for Impact in K-12 and Higher Education EnvironmentsLOS ALAMITOS, Calif., Aug. 12, 2026 /PRNewswire/ -- Epson America has added to its portfolio
More news about: Epson America, Inc.
Aug 12, 2026, 06:00 ET Function Announces Partnership with NYU Grossman School of Medicine to Launch Landmark Research Aimed at Advancing Earlier Disease Detection
too long we have used our best tools last. We typically deploy advanced imaging and/or blood testing only after people are already sick," said Daniel K. Sodickson, M.D., PhD, Chief Medical Scientist at Function and former Chief of Innovation in Radiology at NYU Langone Health. "This partnership flips
More news about: Function Health